Market Cap

Achilles Therapeutics plc Market Capitalization:

$34.3 Million

USD as of Jan. 1, 2024

business Achilles Therapeutics plc Company Profile

Achilles Therapeutics plc Main Stock Listing

NASDAQ: ACHL

Market Capitalization History of Achilles Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Achilles Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 $34.3 M -28.48%
Jan. 1, 2023 $47.9 M -70.92%
Jan. 1, 2022 $164.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Achilles Therapeutics plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Achilles Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: ACHL

Stock: Munich: 698

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.